One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Association Between Age and Low-Density Lipoprotein Cholesterol Response to Statins
Giulia Corn, MSc, PhD, Mads Melbye, MD, DrMedSci, Mark A. Hlatky, MD, Jan Wohlfahrt, MSc, DrMedSci, and Marie Lund, MD, PhD
doi : 10.7326/M22-2643
August 2023Volume 176, Issue 8
Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk Stratification
Laurence Duquenne, MD, Elizabeth M. Hensor, PhD, Michelle Wilson, MSc, Leticia Garcia-Montoya, MD, Jacqueline L. Nam, MBBCh, FCP (SA), Cert Rheum (SA), PhD, Jianhua Wu, PhD, Kate Harnden, MBChB, Innocent Chidi Anioke, MSc, Andrea Di Matteo, PhD, Rahaymin Chowdhury, MBChD, MD, Navkiran Sidhu, MD, Frederique Ponchel, PhD, Kulveer Mankia, MA, DM, BMBCh*, and Paul Emery, MA, MD, MBBChir (Cantab)*
doi : 10.7326/M23-0272
Achievement of Guideline-Recommended Targets in Diabetes Care in China
Victor W. Zhong, PhD*, Dongmei Yu, PhD*, Liyun Zhao, MPH, Yuxiang Yang, MPH, Xiaoguang Li, PhD, Yuge Li, MB, Yue Huang, MPH, Gangqiang Ding, PhD, and Hui Wang, MD, PhD
doi : 10.7326/M23-0442
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone–Salmeterol to Treat Chronic Obstructive Pulmonary Disease
William B. Feldman, MD, DPhil, MPH, Aaron S. Kesselheim, MD, JD, MPH, Jerry Avorn, MD, Massimiliano Russo, PhD, and Shirley V. Wang, PhD
doi : 10.7326/M23-0615
Disparities in Guideline-Recommended Statin Use for Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and Gender
David A. Frank, MPH, Amber E. Johnson, MD, MS, MBA, Leslie R.M. Hausmann, PhD, Walid F. Gellad, MD, MPH, Eric T. Roberts, PhD, and Ravy K. Vajravelu, MD, MSCE
doi : 10.7326/M23-0720
Comparative Effectiveness of Sodium–Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations
Natalie McCormick, PhD*, Chio Yokose, MD, MSc*, Jie Wei, PhD*, Na Lu, MPH, Deborah J. Wexler, MD, MSc, J. Antonio Aviña-Zubieta, MD, PhD, Mary A. De Vera, PhD, Yuqing Zhang, ScD†, and Hyon K. Choi, MD, DrPHâ
doi : 10.7326/M23-0724
Fatal Drug Overdose Risks of Health Care Workers in the United States
Mark Olfson, MD, MPH, Candace M. Cosgrove, MPH, Melanie M. Wall, PhD, and Carlos Blanco, MD, PhD
doi : 10.7326/M23-0902
Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians (Version 2)
Amir Qaseem, MD, PhD, MHA, Curtis S. Harrod, PhD, MPH, Carolyn J. Crandall, MD, MS, and Timothy J. Wilt, MD, MPH, for the Clinical Guidelines Committee of the American College of Physician
doi : 10.7326/M23-0779
How Would You Manage This Patient With Clostridioides difficile Infection?
Zahir Kanjee, MD, MPH, Jessica R. Allegretti, MD, MPH, Carolyn D. Alonso, MD, and Risa B. Burns, MD, MPH
doi : 10.7326/M23-0754
Modernizing the United States’ Public Health Infrastructure: A Position Paper From the American College of Physicians
Ryan Crowley, BSJ, Suja Mathew, MD, and David Hilden, MD, MPH, for the Health and Public Policy Committee of the American College of Physicians
doi : 10.7326/M23-0670
Moving Naloxone Over the Counter Is Necessary but Not Sufficient
John C. Messinger, MD, Leo Beletsky, JD, MPH, Aaron S. Kesselheim, MD, JD, MPH, and Rachel E. Barenie, PharmD, JD, MPH
doi : 10.7326/M23-0852
Addressing Viral Medical Rumors and False or Misleading Information
Hussain S. Lalani, MD, MPH, MSc, Renée DiResta, BS, Richard J. Baron, MD, and David Scales, MD, PhD
doi : 10.7326/M23-1218
Credentialing Internal Medicine Physicians to Expand Long-Acting Reversible Contraceptive Access
Jennifer L. Michener, MD*, David A. Hirsh, MD*, Pelin Batur, MD, Rachel S. Casas, MD, EdM, Vidya Gopinath, MD, Lydia E. Pace, MD, MPH, Christine Prifti, MD, Jennifer Rusiecki, MD, Eleanor Bimla Schwarz, MD, MS, Megha Shankar, MD, Mindy Sobota, MD, MS, MPhil, and Deborah Gomez Kwolek, MD
doi : 10.7326/M23-1034
Reflecting on ACP’s Position Paper for Public Health: A View From the CDC Lens
Sherri A. Berger, MSPH, Rochelle P. Walensky, MD, MPH
doi : 10.7326/M23-1455
New American College of Physicians Guidance on Colorectal Cancer Screening: Less Is More
Michael Bretthauer, MD, PhD, Yu-Xiao Yang, MD
doi : 10.7326/M23-1695
Treatment of Alcohol Use Disorder in Hospitalized Patients: Some Sobering Findings
Michael F. Mayo-Smith, MD, MPH, David Lawrence, MD
doi : 10.7326/M23-1419
Contraception and Reproductive Health Counseling: This Is Our Lane
Amy A. Sarma, MD
doi : 10.7326/M23-1717
Primary Care Physicians: The Bialystok Horses of Health Care?
Eleanor R. Menzin, MD
doi : 10.7326/M23-1353
Pharmacologic Treatment Initiation Among Medicare Beneficiaries Hospitalized With Alcohol Use Disorder
Eden Y. Bernstein, MD, Travis P. Baggett, MD, MPH, Shrunjal Trivedi, MPH, Shoshana J. Herzig, MD, MPH, Timothy S. Anderson, MD, MAS
doi : 10.7326/M23-0641
Impact of Social Needs Case Management on Use of Medical and Behavioral Health Services: Secondary Analysis of a Randomized Controlled Trial
Mark D. Fleming, PhD, MS, Crystal Guo, MPH, Margae Knox, MPH, Daniel M. Brown, PhD, MPH, Elizabeth A. Hernandez, MS, Amanda L. Brewster, PhD, MSc
doi : 10.7326/M23-0876
Tecovirimat Resistance in an Immunocompromised Patient With Mpox and Prolonged Viral Shedding
Helena Mertes, MD*, Antonio Mauro Rezende, MSc, PhD*, Isabel Brosius, MD*, Reinout Naesens, MD, Johan Michiels, BSc, Tessa deBlock, BSc, Jasmine Coppens, MSc, PhD, Christophe Van Dijck, MD, PhD, Peter Bomans, MD, Emmanuel Bottieau, MD, PhD, Marjan Van Esbroeck, MD, Kevin K. Ariën, MSc, PhD, Laurens Liesenborghs, MD, PhD†, Koen Vercauteren, MD, PhDâ€
doi : 10.7326/L23-0131
The Complete Blood Count: Increasing Its Precision and Impact
Stephen D. Sisson, MD
doi : 10.7326/L23-0163
The Complete Blood Count: Increasing Its Precision and Impact
Marko Lucijanic, MD, PhD, and Ivan Krecak, MD, PhD
doi : 10.7326/L23-0164
The Complete Blood Count: Increasing Its Precision and Impact
W. Richard Burack, MD, PhD, and Marshall A. Lichtman, MD
doi : 10.7326/L23-0165
Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes
Jacob M. Hands, BA, Rhonda Patrick, PhD, Leigh A. Frame, PhD
doi : 10.7326/L23-0201
Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes
Anastassios G. Pittas, MD, MS, Tetsuya Kawahara, MD, PhD, Rolf Jorde, MD, PhD, Bess Dawson-Hughes, MD, Ethan M. Balk, MD, MPH
doi : 10.7326/L23-0202
Correction: Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder
doi : 10.7326/L23-0246
Correction: Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease
doi : 10.7326/L23-0249
Correction: Clinical Characteristics and Outcomes Among Travelers With Severe Dengue
doi : 10.7326/L23-0254
Contraception
Rachel Cannon, MD, MSc, Kelly Treder, MD, MPH, Elisabeth J. Woodhams, MD, MSc
doi : 10.7326/AITC202308150
SAEM issued 4 strong recommendations (high-certainty evidence) for determining cause of acute vestibular syndrome in the ED
Jonathan M. Kirschner, MD, Benton R. Hunter, MD
doi : 10.7326/J23-0060
In adults with hypertension, effects of BP-lowering drug monotherapy varied by patient
KoKo Aung, MD, MPH, Thwe Htay, MD
doi : 10.7326/J23-0052
In adults with HF, opioids do not reduce refractory breathlessness (low-certainty evidence)
Muhammad Shahzeb Khan, MD, MSc, Harriette G.C. Van Spall, MD, MPH
doi : 10.7326/J23-0051
In ischemic stroke, EVT improved 90-d function more than usual care across admission SBP levels
Maryam Bahreini, MD, Eddy Lang, MD
doi : 10.7326/J23-0055
In noncardiac surgery, hypotension- vs. hypertension-avoidance strategies did not differ for 30-d major vascular complications
Michael Tanner, MD
doi : 10.7326/J23-0056
In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level
Stephanie Carlin, PharmD, James Douketis, MD
doi : 10.7326/J23-0054
In DVT, oral DTIs and factor Xa inhibitors reduce major bleeding but not recurrent VTE vs. conventional anticoagulants
Alexander P. Benz, MD, John W. Eikelboom, MBBS
doi : 10.7326/J23-0053
In noncritical COVID-19, therapeutic vs. prophylactic anticoagulation did not reduce a composite adverse clinical outcome at 30 d
Thomas G. DeLoughery, MD
doi : 10.7326/J23-0059
In uncontrolled T2DM treated with a basal-bolus insulin regimen, weekly icodec was noninferior to daily glargine for HbA1c at 26 wk
Heiba Belal, MD, Gunjan Y. Gandhi, MD, MSc
doi : 10.7326/J23-0058
In relapsing AAV with rituximab-induced remission, maintenance rituximab vs. azathioprine reduced relapse at ≥32 mo
David S. Pisetsky, MD, PhD
doi : 10.7326/J23-0057
Annals Graphic Medicine - Preparing for a Genomic Future
Courtney J. Smith, and Brian R. Smith
doi : 10.7326/G22-0055
Annals Graphic Medicine - Dr. Mom: The Summer Camp Double Bind
Grace E. Farris, MD
doi : 10.7326/G23-0030
Summary for Patients: Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults
doi : 10.7326/P23-0004
